Liver Transplantation · 2009 · 30 citations · 22 references
MedicineHematologyImmunologyHepatologyStem Cell TransplantationTransplant ImmunologyCorticosteroid Use In TransplantationGraft-versus-host DiseaseHematopoietic Stem Cell Transplant PharmacotherapyLiver Transplant PharmacotherapyLiver TransplantationTransplant ImmunotherapyGraft-versus-host Disease PathophysiologyHematopoietic Stem Cell Transplantation ImmunotherapyHepatic Graft-versus-host DiseaseInflammatory Cytokine EffectsInflammatory Cytokine NetworksInflammatory Cytokine ProfilesLiver Transplantation ManagementSteroid-refractory Graft-versus-host Disease
Acute graft-versus-host disease (GVHD) following orthotopic liver transplantation is a rare but severe disease with a 75% death rate in adults. Various therapeutic strategies have been proposed for steroid-refractory GVHD, but there is still no consensus. Tumor necrosis factor-alpha is a key inflammatory cytokine involved in acute GVHD physiopathology, and infliximab has shown encouraging results for the treatment of acute GVHD following hematopoietic stem cell transplantation. We report the first case of acute GVHD following liver transplantation that was refractory to steroids and anti-lymphocyte globulin but was successfully treated with infliximab.
22
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein et al. · The Lancet · 2002 · 4.2K citations
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
Paul Rutgeerts, William J. Sandborn, Brian G. Feagan et al. · New England Journal of Medicine · 2005 · 3.9K citations · Full text
Ravinder N. Maini, E. William St. Clair, Ferdinand C. Breedveld et al. · The Lancet · 1999 · 2.4K citations
Liver Transplantation in European Patients with the Hepatitis B Surface Antigen
Didier Samuel, R. Müller, Graeme Alexander et al. · New England Journal of Medicine · 1993 · 1.1K citations · Full text
Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial
Umesh Chaudhari, Pat Romano, LD Mulcahy et al. · The Lancet · 2001 · 904 citations